Avedro is seeking to gain FDA approval for its KXL Lasik device platform. The device platform has received CE Mark for sale outside of the US and is currently undergoing Phase III clinical studies within the US.
More Articles on Ophthalmology:
Miller School of Medicine, International Team Discover Seven Genes Linked to Macular Degeneration
Report Estimates Optical Imaging Market Worth $1.9B by 2018
$11.5M in Series A Funding Awarded to Kala Pharmaceuticals
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
